Healthscope


Healthscope is a for-profit Australian company which operates private hospitals, medical centres and International pathology services. The company is headquartered on St Kilda Road, Melbourne. It operates medical/surgical hospitals and a number of psychiatric and rehabilitation clinics.

History

Healthscope is a private healthcare provider in Australia with 45 hospitals. With pathology operations across New Zealand, Malaysia and Singapore.
Formed in 1985, the Healthscope Group has a long history in the private health care industry, and was initially listed on the Australian Securities Exchange in 1994.
In October 2010 the Healthscope business was acquired by a consortium of funds, advised and managed by TPG Capital and The Carlyle Group and was subsequently de-listed from the ASX. Following a period of successful growth under private ownership, the Healthscope business was re-listed on the ASX on 28 July 2014.
In July 2015 Healthscope sold its Australian Pathology division to Crescent Capital Partners.
In August 2017, Healthscope sold their Medical Centres portfolio to Singapore-based Fullerton Healthcare.
On 6 June 2019, Canadian firm Brookfield Business Partners LLP announced completion of its takeover of Healthscope. Brookfield partnered with institutional investors including the Caisse de dépôt et placement du Québec, and the CDPQ maintains a minority stake in Healthscope.

Hospitals and facilities run by Healthscope

Hospitals

Healthscope operates and manages 46 private hospitals in Australia, seven mental health facilities, six rehabilitation and extended care facilities.
Healthscope Hospitals is the largest operator of private inpatient mental health facilities in Australia with 14 hospitals providing care.
Healthscope Hospitals provide treatment for mental health issues and for drug and alcohol abuse.
Healthscope Hospitals offering Mental Health Services

The programs available at Healthscope Hospitals include:
Healthscope Hospitals offering Rehabilitation Services

In July 2015 Healthscope sold its Australian Pathology business to Crescent Capital Partners. Healthscope retains its International Pathology division.

Healthscope Medical Centres

In August 2017, Healthscope sold their Medical Centres division including a portfolio of 43 medical centres, four specialist skin clinics and one specialist breast diagnostic clinic to Fullerton Health Care.

Healthscope Independence Services

Healthscope Independence Services is a provider of unique accommodation, attendant care and in-home services to individuals with acquired brain injuries, other disabilities or complex conditions and others leaving hospital requiring extra support at home.
Healthscope Independence Services provides long-term, short-term, transitional and respite options in metropolitan Melbourne, regional Victoria, New South Wales and Darwin in the Northern Territory.

Ownership

Healthscope was a public company whose stock was traded on the Australian Stock Exchange under the stock code HSP. The company completed an Initial Public Offering in 1994 when it raised A$70 million by issuing 40 million shares at A$1.75 each. In 2010, Healthscope was acquired by The Carlyle Group. It was managed by TPG and The Carlyle Group and was later re-added to the ASX on 28 July 2014. From July 2014, Healthscope stock was again part of the S&P/ASX 200 Index under the stock code HSO. As at June 2019, Healthscope was removed from the official list of ASX traded companies due to the Brookfield takeover.

Management

The managing director and chief executive officer is Steven Rubic.